Hot Investor Mandate: Global Investment Firm with USA Office Invests Broadly Across All Life Science Industries in USA, Canada, and China

A venture capital investment firm established in China with an additional office in the USA is investing from a fund with a focus on high-tech enterprises in China and western countries. The company seeks to invest in innovative enterprises in sectors including: biomedicine, medical devices, healthcare and bio-tech. Typical equity investments range from $1-6 million in Angel, Series A and B rounds. The firm is looking for opportunities in China, the US and Canada.

Within healthcare, the firm considers biomedicine, medical devices, and digital health. The firm is most interested in personalized medicine products with an angle to the China market. Within digital health, the firm prefers home-care, consumer, or physician-patient interface products. The firm considers products from Angel Round to Series B.

The firm is looking for competent management teams. The firm may request distribution rights on a case-by-case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.